Diagnosis et Treatment of Asthma in Athlete : Boundary Between Disease and Doping (SALBEXO)

Toulouse University Hospital

Status and phase: Completed; Phase 4

Conditions: Asthma

Treatments: Other: urine sample; Other: blood sample

Study type: Interventional

Funder types: Other

Identifiers

NCT02655328

08 301 03

Details and patient eligibility

About

This study will determine the pharmacokinetic profile of the salbutamol concentration in the urine while athletes are resting or during exercise.

Enrollment: 14 patients

Sex: Male

Ages: 18 to 40 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patient who hold a license in a sport federation, and do at least 8 hours of sport each week
• asthmatic patient

Exclusion criteria

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

14 participants in 1 patient group

athlete under asthma treatment

Experimental group

Description:

athlete suffering from asthma blood sample urine sample

Treatment:

Other: urine sample

Other: blood sample